US EditionMounjaro manufacturer pauses UK shipments of weight loss drug ahead of price hike
Eli Lilly halted UK shipments of Mounjaro to manage unprecedented demand ahead of a 170% price increase, with pharmacies experiencing shortages and legal stockpiling restrictions in place.
- Eli Lilly has temporarily stopped distributing its weight-loss medication Mounjaro in the UK as it prepares for a significant price increase of up to 170% starting September 1.
- The pause aims to manage stock amid soaring demand following the announced price hike, which aligns UK prices with other European markets under White House encouragement.
- Major UK pharmacies like Superdrug and Lloyds reported shortages, while companies restricted sales to existing patients and limited supplies to prevent bulk buying.
- A month's supply at the highest dose will rise from £122 to £330, and Lilly stated legal protections prevent inappropriate stockpiling to ensure patient access is maintained.
- The disruption highlights affordability concerns for many British users, with only one in ten accessing Mounjaro free via NHS, while orders are planned to resume from September 1.
Insights by Ground AI
Does this summary seem wrong?
19 Articles
19 Articles
Coverage Details
Total News Sources19
Leaning Left2Leaning Right2Center10Last UpdatedBias Distribution71% Center
Bias Distribution
- 71% of the sources are Center
71% Center
14%
C 71%
14%
Factuality
To view factuality data please Upgrade to Premium
